Peripheral CD8+ T Cells Predicts Immune-Related Adverse Events and Survival in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy

被引：0
|
作者：
Wu, K. [1 ]
Yang, S. [1 ]
Li, X. [1 ]
Xia, B. [1 ]
Ma, S. [1 ]
Chen, X. [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hangzhou Canc Hosp, Hangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
immune-related adverse events; non-small cell lung cancer; Peripheral CD8+T cells;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA09.03
引用
收藏
页码：S911 / S912
页数：2
相关论文
共 50 条
  • [41] The Role of Immune-Related Adverse Events in Prognosis and Efficacy Prediction for Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: A Retrospective Clinical Analysis
    Sonehara, Kei
    Tateishi, Kazunari
    Araki, Taisuke
    Komatsu, Masamichi
    Yamamoto, Hiroshi
    Koizumi, Tomonobu
    Hanaoka, Masayuki
    ONCOLOGY, 2021, 99 (05) : 271 - 279
  • [42] Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
    Sung, Mike
    Zer, Mona
    Walia, Preet
    Khoja, Leila
    Maganti, Manjula
    Labbe, Catherine
    Shepherd, Frances A.
    Bradbury, Penelope A.
    Liu, Geoffrey
    Leighl, Natasha B.
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2706 - 2712
  • [43] Immune-related adverse events in non-small cell lung cancer: Occurrence, mechanisms and therapeutic strategies
    Lin, Xuwen
    Xie, Mei
    Yao, Jie
    Ma, Xidong
    Qin, Lin
    Zhang, Xu-Mei
    Song, Jialin
    Bao, Xinyu
    Zhang, Xin
    Zhang, Yinguang
    Liu, Yiming
    Han, Wenya
    Liang, Yiran
    Jing, Ying
    Xue, Xinying
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (03):
  • [44] Peripheral absolute eosinophil count identifies the risk of serious immune-related adverse events in non-small cell lung cancer
    Wu, Yan
    Li, Dapeng
    Wu, Mengyao
    Yang, Ying
    Shen, Meng
    Chen, Kai
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Patterns and prognostic significance of cutaneous immune-related adverse events in non-small cell lung cancer
    Thompson, Leah L.
    Nadelmann, Emily R.
    Blum, Amy E.
    Yoon, Jaewon
    Polyakov, Nicole J.
    Kagan, Ruth D.
    Gainor, Justin F.
    Mooradian, Meghan J.
    Chen, Steven T.
    EUROPEAN JOURNAL OF CANCER, 2021, 147 : 13 - 16
  • [46] Immune-Related Adverse Events and Their Effect on Outcomes in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab
    Kothari, Shawn
    Bagley, Stephen
    Aggarwal, Charu
    Baum, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1290 - S1290
  • [47] Upfront atezolizumab chemoimmunotherapy-associated immune-related adverse events in patients with advanced non-small cell lung cancer
    Mogollon-Duffo, F.
    Thein, K. Z.
    Tun, A. M.
    Swarup, S.
    Jahan, N.
    Adhikari, N.
    Htut, T. Win
    Naing, T. W.
    Hlaing, P. P.
    Myat, Y. Mon
    Naing, P. T.
    Hardwicke, F.
    Tijani, L.
    D'Cunha, N.
    Awasthi, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [48] Peripheral blood biomarkers predict immune-related adverse events in non-small cell lung cancer patients treated with pembrolizumab: a multicenter retrospective study
    Egami, Saeka
    Kawazoe, Hitoshi
    Hashimoto, Hironobu
    Uozumi, Ryuji
    Arami, Toko
    Sakiyama, Naomi
    Ohe, Yuichiro
    Nakada, Hideo
    Aomori, Tohru
    Ikemura, Shinnosuke
    Fukunaga, Koichi
    Yamaguchi, Masakazu
    Nakamura, Tomonori
    JOURNAL OF CANCER, 2021, 12 (07): : 2105 - 2112
  • [49] Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study
    Teraoka, Shunsuke
    Fujimoto, Daichi
    Morimoto, Takeshi
    Kawachi, Hayato
    Ito, Munehiro
    Sato, Yuki
    Nagata, Kazuma
    Nakagawa, Atsushi
    Otsuka, Kojiro
    Uehara, Keiichiro
    Imai, Yukihiro
    Ishida, Kaori
    Fukuoka, Junya
    Tomii, Keisuke
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (12) : 1798 - 1805
  • [50] Immune-related adverse events in patients with stage IV non-small cell lung cancer on immunotherapy: experience from the West of Scotland
    Downham, E.
    Maclaren, V.
    Mcloone, P.
    LUNG CANCER, 2019, 127 : S42 - S42
12345